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ratio: 2,43; 65-74 yrs old: 4,72%,I$ 25968, age ratio: 1,31; 75-84 yrs old: 8,45%; I$ 15471, age 
ratio: 0,78; 85+ yrs old: 14,09%, I$ 7832, age ratio: 0,39), and sex, males (47,4%) had a I$: 
22679 (M/F I$ ratio: 1,45). In 1 adm.(53% of deaths), mean cost was I$ 23 792; while ReH 
≤ 365 days (47% of deaths), I$ 13 530, cost ratio ReH/1 adm= 0,57 ; and if ReH < 30 days 
(29,5%), I$ 12354, cost ratio ReH< 30/1 adm= 0,52. ConClusions: Understanding the 
economic burden of dying helps promote better and cost-effective ways of promoting 
palliative care, old and readmitted deaths are less costly.
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objeCtives: Brand-Generic scheme was implemented in Iran to improve the compe-
tition in the market. In this study we aim to assess if this new policy has had any posi-
tive effect on efficiency of Iranian pharmaceutical companies. Methods: We used 
Data Envelopment Analysis (DEA) to evaluate the relative efficiency of pharmaceutical 
companies for the years 1999-2008. The Wilcoxon matched-pairs signed-rank test and 
also sign test were used to assess the difference between mean relative efficiency of 
companies before and after policy. Results: Although the Wilcoxon matched-pairs 
signed-rank test did not show any significant difference between before and after 
new policy in term of both technical and pure (managerial) efficiency of included 
companies (Pvalue: 0.079 and 0.07, respectively) but the one–sided sign test indicated 
that only relative pure (managerial) efficiency has improved after this policy (Pvalue: 
0.031). ConClusions: The “Brand-Generic scheme” does not seem to be enough 
policy to improve efficiency of pharmaceutical companies in Iran. To achieve this aim, 
paying special attention to infrastructural requirements including non-discriminating 
and transparent laws and regulations for supporting competition, the competitive 
pricing policies, the presence of international companies in the market and full pri-
vatization of companies had to be also considered by policy makers.
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objeCtives: To describe the main actions promoted by the The Federal Regulatory 
Agency for Private Health Insurance and Plans (ANS) to regulate the access 
of private health plans beneficiaries to an adequate and an integral assis-
tance. Methods: A retrospective analysis of data about coverage in health plans 
since ANS creation (1999) was done to identify the main actions promoted by the 
agency in this area. It included the set of rules published and ANS periodic publi-
cations. Results: A very important identified mechanism that ANS employs for 
regulating the users access to a full assistance is the elaboration of a list of medical 
procedures. This list constitutes the minimum obligatory coverage for all plans. It 
is periodically reviewed and incorporations and/or exclusions are made according 
to some precepts like: clinical evidence, epidemiological relevance, among oth-
ers. The guidelines implementation is another important instrument identified 
in this study to the improvement of private health assistance. ANS established a 
collaboration term with the Brazilian Medical Association (AMB) to develop guide-
lines, to spread and to monitor their implementation. ConClusions: The actions 
presented are the main one promoted by ANS to regulate the access to an ade-
quate and an integral assistance. They can also improve the sector efficiency along 
with the rational use of techniques and medical technologies. The instruments 
discussed will be a guide to upgrade the health plans management and their 
efficiency. The patients will have safer end more effective treatments and ANS 
keeps the balance and promotion of health in private health with a new model.
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objetivos: Demonstrar a eficácia da utilização de meios consensuais de mediação 
de conflitos pela Administração Pública no controle e fiscalização do cumprimento 
das normas que regulam a assistência suplementar à saúde no Brasil. Métodos: 
Desde 2010, a ANS – Agência Nacional de Saúde Suplementar implementou o procedi-
mento NIP (Notificação de Investiação Preliminar), cujo objetivo é realizar a mediação 
de conflitos entre operadoras de planos de saúde e consumidores, no que tange a 
situações que envolvem negativa de cobertura assistencial. A NIP é um processo 
totalmente eletrônico, que confere maior celeridade e eficácia na resolução das rec-
lamações dos consumidores, induzindo uma melhora na relação operadora/consu-
midor. Com a NIP, as operadoras têm prazo de 5 dias para solucionar o conflito junto 
ao beneficiário e responder à ANS sobre as medidas tomadas. Após processamento na 
NIP, a reclamação pode ser finalizada por inexistência de infração, reparação de con-
duta ou encaminhada para abertura de processo administrativo, nos casos em que o 
conflito não foi resolvido. ResultAdos: Desde sua implementação, a resolutividade 
dos conflitos na NIP manteve-se acima de 70% do total de reclamações recebidas, o 
que em 2012 significou a conclusão de 42.672 das 54.412 denúncias de negativa de 
cobertura assistencial (78,4% de resolutividade). Antes de seu advento, as reclamações 
eram analisadas por meio de instituição de processo administrativo sancionador, que 
duravam, em média, 18-24 meses para sua conclusão, podendo levar ao arquivamento 
da denúncia ou lavratura de auto de infração contra a operadora. ConClusões: A 
NIP conferiu maior eficácia ao processo fiscalizatório da ANS, proporcionando maior 
to be concentrated among the rich in both years. Decomposition indicated that 
“illegitimate” factors remained large contributors to income-related inequality in 
SRHS even after the equity-centered reform of 2005. ConClusions: Findings sug-
gest that income-related inequality in SRHS might have decreased in Chile after 
the health care reform. Beyond this observed difference over time, the remaining 
inequality is still largely due to illegitimate factors that should be tackled through 
broader policies in the country.
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objeCtives: To characterize the users of access to medicines program developed 
in Brazil, known as Aqui Tem Farmácia Popular Program (PAFP), by identifying those 
users who migrated from other supply of basic medicines programs by means of a 
survey explicitly developed for this purpose. This work also seeks to evaluate the 
meeting customers’ needs by the Program and its satisfaction level. Methods: The 
survey instrument used gathering the users of Aqui Tem Farmácia Popular program 
has been applied in 15 counties from 14 Brazilian states. 1073 interviews com-
posed the sample, in 27 establishments of private pharmacies, during august 2012. 
The collection instrument was composed by three blocks: questions concerning 
the use of the PAFP and other programs of medicines supply; user’s profile infor-
mation; and identification of the medicine supplied. Results: The evaluation of 
the users migration from other programs identified that, before the PAFP, 52% of 
interviewed users was buying the medicines in the private pharmacy and more 
than 30% was using the Public Service in a Health Center of SUS, a piece of 11% 
began the treatment after the PAFP. More than 58% of users would use the service 
of the SUS if there was no PAFP. However, 36% of users reported that they would 
not use the SUS system for withdrawal of medicines. It was observed that 61% of 
users gave out to be economizing while withdrawing the medicines with gratuity 
or at a discount. ConClusions: The conducted survey made possible to character-
ize the users of PAFP showing aspects concerning the participation and the range 
of the program. Generally, it was found that the persons are satisfied and they 
reported to have saved with the program. They also pointed out the convenience 
they have with the possibility of the access to the medicine in any pharmacy with 
the PAFP.
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objeCtives: To explore safety culture dimensions among health care professionals 
using Hospital Survey on Patient Safety Culture (HSOPSC) by developed by AHRQ 
(Agency for Healthcare Research and Quality). Methods: We surveyed nationwide 
the situation of patient safety culture in 13 hospitals (5,760 persons) allowed for 
additional costs on patient safety countermeasures under the social insurance med-
ical fee schedule. The questionnaire consists of seven unit-level aspects of safety 
culture including 24 items, three hospital-level including 11 items, and four outcome 
variables including nine items. Results: An average number of beds was 360 beds 
(63 - 1,354 beds). With regard to ownership, 13 hospitals included three municipality 
and local incorporated agency hospitals, one public hospital, two juridical person 
with social insurance hospitals, six medical corporation hospitals, and one other 
hospital. Number of all respondents was 5,118 persons (response rate: 88.9%), and 
included 295 physicians (90.8%), 2,909 nurses (95.5%), and 146 pharmacists (96.7%). 
In terms of 12 dimensions, the overall average positive response rate (RR) for the 
12 patient safety dimensions of the HSOPS was 49.2%, extremely lower than the 
average positive RR for the AHRQ data (61%). In terms of health care professionals, 
the overall average positive RR for pharmacists (46.2%) was lower than that for 
physicians and nurses (49.6% and 49.4%).With regard to pharmacists, the aver-
age positive RRs for 8 dimensions of the 12 dimensions were the lowest among 
three professionals, and three average positive RRs were the highest; Frequency of 
event reporting (pharmacists: physicians: nurses= 73.6%:53.3%:67.9%), Non-punitive 
response to error (48.8%:42.6%:40.4%), and Staffing (29.1%:27.0%:25.4%). ConClus
ions: The HSOPSC measurement provides the evidence for assessment of patient 
safety culture in Japan’s hospitals. This result that patient safety culture has been 
in a state of development, compared with the US hospitals.
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objeCtives: Little is known about dying in Argentina, we studied costs and readmis-
sions (ReH) < 30 days of hospital dying adults. Methods: A cross sectional study of 1 
year hospital discharges, with HCUPs methods, of patients ≥ 19 yrs old. We obtained 
deaths, first admission (1 adm) and ReH ≤ 365 days and ReH < 30 days; total direct 
medical cost (TC I$), mean (I$) (SD), median I$ (Q1-Q3) discharge cost, (in I$ PPP, 2008), 
stratified by age/sex, admissions and ReH < 30 days and < 365 days. Results: Total 
mortality for ≥ 19 yrs old patients was 4,70%. Among 2137 deaths, Total cost of those 
dead in hospital, TC I$: 40 540 842 ; mean cost per discharge (I$) was 19853 (SD 45 599); 
Median cost per discharge I$ 4182; (Q1: 1452-Q3: 17730 I$), comprising 8,31 % of TC I$. 
Among 43321 discharges, TC$ of those alive, TC: 447 300 754 I$; mean cost per discharge 
($) was 10569 I$ (SD 21 217); Median cost per discharge 14 091 I$; (Q1: 2 496- Q3:10 054 
I$). Relative dead /alive I$ was 1,88 times higher. Mean discharge cost of deceased 
stratified by age group (mortality 19-64 yrs. old: 1,52%, I$ 48332, age 19-64/≥ 19 yrs old 
